Structure

Physi-Chem Properties

Molecular Weight:  480.11
Volume:  457.075
LogP:  3.546
LogD:  2.481
LogS:  -4.711
# Rotatable Bonds:  4
TPSA:  159.05
# H-Bond Aceptor:  10
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.294
Synthetic Accessibility Score:  3.679
Fsp3:  0.16
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  2
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.719
MDCK Permeability:  1.292312936129747e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.034
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.257

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  95.1539535522461%
Volume Distribution (VD):  0.506
Pgp-substrate:  9.644318580627441%

ADMET: Metabolism

CYP1A2-inhibitor:  0.302
CYP1A2-substrate:  0.188
CYP2C19-inhibitor:  0.155
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.852
CYP2C9-substrate:  0.7
CYP2D6-inhibitor:  0.137
CYP2D6-substrate:  0.23
CYP3A4-inhibitor:  0.332
CYP3A4-substrate:  0.198

ADMET: Excretion

Clearance (CL):  3.087
Half-life (T1/2):  0.845

ADMET: Toxicity

hERG Blockers:  0.098
Human Hepatotoxicity (H-HT):  0.461
Drug-inuced Liver Injury (DILI):  0.987
AMES Toxicity:  0.689
Rat Oral Acute Toxicity:  0.329
Maximum Recommended Daily Dose:  0.025
Skin Sensitization:  0.371
Carcinogencity:  0.384
Eye Corrosion:  0.003
Eye Irritation:  0.775
Respiratory Toxicity:  0.019

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC295082

Natural Product ID:  NPC295082
Common Name*:   Rhodiolinin
IUPAC Name:   (2R,3R)-6,8-dihydroxy-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-9-(4-hydroxyphenyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-7-one
Synonyms:   Rhodiolinin
Standard InCHIKey:  POVCYOFRCMBMKD-XMSQKQJNSA-N
Standard InCHI:  InChI=1S/C25H20O10/c1-32-16-8-12(4-7-14(16)28)22-18(10-26)34-24-17(33-22)9-15(29)19-20(30)21(31)23(35-25(19)24)11-2-5-13(27)6-3-11/h2-9,18,22,26-29,31H,10H2,1H3/t18-,22-/m1/s1
SMILES:  COc1cc(ccc1O)[C@@H]1[C@@H](CO)Oc2c(cc(c3c(=O)c(c(c4ccc(cc4)O)oc23)O)O)O1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL594871
PubChem CID:   14778358
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001844] Flavonolignans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16239 Rhodiola rosea Species Crassulaceae Eukaryota roots n.a. n.a. PMID[19729316]
NPO16239 Rhodiola rosea Species Crassulaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16239 Rhodiola rosea Species Crassulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT616 Cell Line MDCK Canis lupus familiaris CC50 > 300000.0 nM PMID[469569]
NPT493 Individual Protein Neuraminidase Influenza A virus Ki = 14100.0 nM PMID[469569]
NPT493 Individual Protein Neuraminidase Influenza A virus IC50 = 10300.0 nM PMID[469569]
NPT344 Individual Protein Sialidase Clostridium perfringens IC50 = 6100.0 nM PMID[469569]
NPT2 Others Unspecified Ratio CC50/EC50 > 7.19 n.a. PMID[469569]
NPT742 Organism Influenza A virus Influenza A virus EC50 = 29300.0 nM PMID[469569]
NPT1453 Organism Influenza A virus (A/PR/8/34(H1N1)) Influenza A virus (A/Puerto Rico/8/1934(H1N1)) EC50 = 41700.0 nM PMID[469569]
NPT2 Others Unspecified Ratio CC50/EC50 > 10.24 n.a. PMID[469569]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC295082 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9748 High Similarity NPC243877
0.9682 High Similarity NPC66618
0.9682 High Similarity NPC113163
0.9682 High Similarity NPC84324
0.9682 High Similarity NPC165970
0.9682 High Similarity NPC305987
0.9682 High Similarity NPC288131
0.9625 High Similarity NPC14662
0.9623 High Similarity NPC7688
0.9623 High Similarity NPC7154
0.9623 High Similarity NPC125039
0.9623 High Similarity NPC58223
0.9623 High Similarity NPC36916
0.9623 High Similarity NPC72787
0.9623 High Similarity NPC36
0.9618 High Similarity NPC101731
0.9554 High Similarity NPC172202
0.9554 High Similarity NPC284127
0.9554 High Similarity NPC476410
0.9503 High Similarity NPC260266
0.9494 High Similarity NPC263449
0.949 High Similarity NPC93376
0.949 High Similarity NPC75215
0.949 High Similarity NPC189179
0.949 High Similarity NPC227192
0.949 High Similarity NPC183851
0.949 High Similarity NPC470402
0.949 High Similarity NPC63454
0.949 High Similarity NPC224137
0.9448 High Similarity NPC476405
0.9448 High Similarity NPC117260
0.9437 High Similarity NPC272064
0.9434 High Similarity NPC308992
0.9434 High Similarity NPC158188
0.943 High Similarity NPC204854
0.943 High Similarity NPC191459
0.943 High Similarity NPC253634
0.943 High Similarity NPC7846
0.943 High Similarity NPC130894
0.943 High Similarity NPC4481
0.943 High Similarity NPC25495
0.943 High Similarity NPC9609
0.943 High Similarity NPC22472
0.943 High Similarity NPC19687
0.943 High Similarity NPC18772
0.943 High Similarity NPC261004
0.943 High Similarity NPC18607
0.943 High Similarity NPC288669
0.943 High Similarity NPC176300
0.943 High Similarity NPC152166
0.943 High Similarity NPC143828
0.943 High Similarity NPC300943
0.943 High Similarity NPC115798
0.943 High Similarity NPC105242
0.9427 High Similarity NPC49824
0.9427 High Similarity NPC247017
0.9427 High Similarity NPC474520
0.9427 High Similarity NPC98661
0.9401 High Similarity NPC36138
0.9394 High Similarity NPC169733
0.939 High Similarity NPC101026
0.939 High Similarity NPC169977
0.939 High Similarity NPC24043
0.939 High Similarity NPC21666
0.939 High Similarity NPC42773
0.939 High Similarity NPC45522
0.9387 High Similarity NPC245014
0.9387 High Similarity NPC84265
0.9387 High Similarity NPC282987
0.9379 High Similarity NPC470457
0.9379 High Similarity NPC224280
0.9375 High Similarity NPC219927
0.9367 High Similarity NPC176665
0.9367 High Similarity NPC29841
0.9367 High Similarity NPC475267
0.9367 High Similarity NPC162869
0.9367 High Similarity NPC305663
0.9367 High Similarity NPC156057
0.9367 High Similarity NPC235215
0.9367 High Similarity NPC163524
0.9367 High Similarity NPC203891
0.9367 High Similarity NPC110070
0.9367 High Similarity NPC474208
0.9367 High Similarity NPC287979
0.9367 High Similarity NPC101830
0.9367 High Similarity NPC48208
0.9367 High Similarity NPC7973
0.9367 High Similarity NPC472438
0.9367 High Similarity NPC474836
0.9367 High Similarity NPC78302
0.9363 High Similarity NPC201136
0.9363 High Similarity NPC196439
0.9363 High Similarity NPC4455
0.9363 High Similarity NPC138360
0.9363 High Similarity NPC280339
0.9363 High Similarity NPC201451
0.9363 High Similarity NPC213622
0.9363 High Similarity NPC146165
0.9363 High Similarity NPC92659
0.9363 High Similarity NPC183597
0.9363 High Similarity NPC227325
0.9363 High Similarity NPC44079
0.9363 High Similarity NPC167815
0.9363 High Similarity NPC26227
0.9363 High Similarity NPC163780
0.9363 High Similarity NPC50715
0.9363 High Similarity NPC2476
0.9363 High Similarity NPC128863
0.9345 High Similarity NPC470416
0.9333 High Similarity NPC477848
0.9325 High Similarity NPC280493
0.9325 High Similarity NPC226294
0.9325 High Similarity NPC469931
0.9325 High Similarity NPC45638
0.9325 High Similarity NPC93337
0.9325 High Similarity NPC186807
0.9325 High Similarity NPC475942
0.9325 High Similarity NPC177480
0.9325 High Similarity NPC58053
0.9325 High Similarity NPC105025
0.9325 High Similarity NPC475212
0.9325 High Similarity NPC201292
0.9317 High Similarity NPC470459
0.9317 High Similarity NPC472625
0.9313 High Similarity NPC34089
0.9313 High Similarity NPC471499
0.9313 High Similarity NPC289771
0.9313 High Similarity NPC142252
0.9313 High Similarity NPC26326
0.9313 High Similarity NPC196179
0.9308 High Similarity NPC193842
0.9308 High Similarity NPC152904
0.9304 High Similarity NPC320825
0.9304 High Similarity NPC235165
0.9304 High Similarity NPC201837
0.9304 High Similarity NPC43243
0.9304 High Similarity NPC250922
0.9304 High Similarity NPC13858
0.9304 High Similarity NPC266960
0.9304 High Similarity NPC178854
0.9304 High Similarity NPC292107
0.9304 High Similarity NPC200388
0.9304 High Similarity NPC245546
0.9304 High Similarity NPC472916
0.9304 High Similarity NPC100916
0.9304 High Similarity NPC268161
0.9304 High Similarity NPC326037
0.9304 High Similarity NPC55619
0.9304 High Similarity NPC255106
0.9299 High Similarity NPC69394
0.9299 High Similarity NPC22519
0.9299 High Similarity NPC145379
0.9299 High Similarity NPC231018
0.9299 High Similarity NPC276409
0.9299 High Similarity NPC274327
0.9299 High Similarity NPC183878
0.9299 High Similarity NPC255350
0.9299 High Similarity NPC86485
0.9299 High Similarity NPC176775
0.9299 High Similarity NPC250822
0.9299 High Similarity NPC75279
0.9299 High Similarity NPC160951
0.9299 High Similarity NPC47781
0.9281 High Similarity NPC470444
0.9281 High Similarity NPC473682
0.9281 High Similarity NPC241423
0.9281 High Similarity NPC324742
0.9281 High Similarity NPC110941
0.9281 High Similarity NPC126784
0.9281 High Similarity NPC473571
0.9281 High Similarity NPC470443
0.9277 High Similarity NPC472385
0.9277 High Similarity NPC198324
0.9277 High Similarity NPC470949
0.9277 High Similarity NPC472992
0.9277 High Similarity NPC472991
0.9277 High Similarity NPC211532
0.9277 High Similarity NPC65563
0.9277 High Similarity NPC8573
0.9277 High Similarity NPC233994
0.9273 High Similarity NPC204693
0.9268 High Similarity NPC102277
0.9268 High Similarity NPC279209
0.9264 High Similarity NPC146792
0.9264 High Similarity NPC158761
0.9264 High Similarity NPC45618
0.9264 High Similarity NPC470456
0.9264 High Similarity NPC58716
0.9259 High Similarity NPC142614
0.9259 High Similarity NPC477840
0.9259 High Similarity NPC234052
0.9255 High Similarity NPC476247
0.9255 High Similarity NPC477841
0.925 High Similarity NPC470326
0.925 High Similarity NPC282009
0.925 High Similarity NPC287328
0.9245 High Similarity NPC471515
0.9245 High Similarity NPC472911
0.9245 High Similarity NPC96167
0.9245 High Similarity NPC472914

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC295082 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9623 High Similarity NPD6166 Phase 2
0.9623 High Similarity NPD6167 Clinical (unspecified phase)
0.9623 High Similarity NPD6168 Clinical (unspecified phase)
0.9299 High Similarity NPD2801 Approved
0.9217 High Similarity NPD4338 Clinical (unspecified phase)
0.9114 High Similarity NPD1934 Approved
0.9096 High Similarity NPD6797 Phase 2
0.9091 High Similarity NPD7054 Approved
0.9042 High Similarity NPD7251 Discontinued
0.9036 High Similarity NPD7472 Approved
0.8988 High Similarity NPD7808 Phase 3
0.8944 High Similarity NPD3882 Suspended
0.8938 High Similarity NPD2393 Clinical (unspecified phase)
0.8922 High Similarity NPD7074 Phase 3
0.8882 High Similarity NPD3817 Phase 2
0.8854 High Similarity NPD1512 Approved
0.8827 High Similarity NPD4868 Clinical (unspecified phase)
0.8802 High Similarity NPD3818 Discontinued
0.8757 High Similarity NPD7993 Clinical (unspecified phase)
0.8726 High Similarity NPD1511 Approved
0.865 High Similarity NPD5402 Approved
0.8634 High Similarity NPD4380 Phase 2
0.8554 High Similarity NPD5494 Approved
0.8545 High Similarity NPD4381 Clinical (unspecified phase)
0.8529 High Similarity NPD7804 Clinical (unspecified phase)
0.8438 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8434 Intermediate Similarity NPD7075 Discontinued
0.8421 Intermediate Similarity NPD5844 Phase 1
0.8313 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD6801 Discontinued
0.8284 Intermediate Similarity NPD6959 Discontinued
0.8253 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD6232 Discontinued
0.8228 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD5403 Approved
0.821 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8198 Intermediate Similarity NPD7473 Discontinued
0.8176 Intermediate Similarity NPD1549 Phase 2
0.8148 Intermediate Similarity NPD6799 Approved
0.8133 Intermediate Similarity NPD7411 Suspended
0.8098 Intermediate Similarity NPD5401 Approved
0.807 Intermediate Similarity NPD1247 Approved
0.805 Intermediate Similarity NPD2796 Approved
0.8046 Intermediate Similarity NPD3751 Discontinued
0.8036 Intermediate Similarity NPD1465 Phase 2
0.8023 Intermediate Similarity NPD3787 Discontinued
0.7987 Intermediate Similarity NPD1510 Phase 2
0.7977 Intermediate Similarity NPD3926 Phase 2
0.7967 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7966 Intermediate Similarity NPD6559 Discontinued
0.7956 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD7819 Suspended
0.7914 Intermediate Similarity NPD6190 Approved
0.7857 Intermediate Similarity NPD6599 Discontinued
0.7848 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD1613 Approved
0.7844 Intermediate Similarity NPD1653 Approved
0.779 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD919 Approved
0.7736 Intermediate Similarity NPD1240 Approved
0.7736 Intermediate Similarity NPD943 Approved
0.7688 Intermediate Similarity NPD3749 Approved
0.7679 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7672 Intermediate Similarity NPD6778 Approved
0.7672 Intermediate Similarity NPD6776 Approved
0.7672 Intermediate Similarity NPD6777 Approved
0.7672 Intermediate Similarity NPD6779 Approved
0.7672 Intermediate Similarity NPD6781 Approved
0.7672 Intermediate Similarity NPD6782 Approved
0.7672 Intermediate Similarity NPD6780 Approved
0.767 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD3027 Phase 3
0.7657 Intermediate Similarity NPD7199 Phase 2
0.764 Intermediate Similarity NPD1607 Approved
0.764 Intermediate Similarity NPD7228 Approved
0.763 Intermediate Similarity NPD7768 Phase 2
0.7622 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD8312 Approved
0.7582 Intermediate Similarity NPD8313 Approved
0.7578 Intermediate Similarity NPD230 Phase 1
0.7569 Intermediate Similarity NPD7685 Pre-registration
0.7554 Intermediate Similarity NPD8150 Discontinued
0.7552 Intermediate Similarity NPD7435 Discontinued
0.7546 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD6234 Discontinued
0.7532 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD3750 Approved
0.7513 Intermediate Similarity NPD7870 Phase 2
0.7513 Intermediate Similarity NPD7871 Phase 2
0.75 Intermediate Similarity NPD2935 Discontinued
0.747 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD447 Suspended
0.7461 Intermediate Similarity NPD7698 Approved
0.7461 Intermediate Similarity NPD7696 Phase 3
0.7461 Intermediate Similarity NPD7697 Approved
0.7457 Intermediate Similarity NPD6844 Discontinued
0.7457 Intermediate Similarity NPD37 Approved
0.7453 Intermediate Similarity NPD6233 Phase 2
0.7429 Intermediate Similarity NPD4965 Approved
0.7429 Intermediate Similarity NPD4967 Phase 2
0.7429 Intermediate Similarity NPD4966 Approved
0.7425 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD4628 Phase 3
0.7407 Intermediate Similarity NPD6534 Approved
0.7407 Intermediate Similarity NPD6535 Approved
0.7398 Intermediate Similarity NPD7701 Phase 2
0.7396 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD7390 Discontinued
0.7396 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1551 Phase 2
0.7391 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD4908 Phase 1
0.7374 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD7783 Phase 2
0.7366 Intermediate Similarity NPD8434 Phase 2
0.7365 Intermediate Similarity NPD2800 Approved
0.736 Intermediate Similarity NPD8151 Discontinued
0.7353 Intermediate Similarity NPD2533 Approved
0.7353 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD2534 Approved
0.7353 Intermediate Similarity NPD2532 Approved
0.7323 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD7874 Approved
0.7312 Intermediate Similarity NPD9494 Approved
0.7292 Intermediate Similarity NPD7700 Phase 2
0.7292 Intermediate Similarity NPD7699 Phase 2
0.7286 Intermediate Similarity NPD7801 Approved
0.7284 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD6798 Discontinued
0.7283 Intermediate Similarity NPD3226 Approved
0.7267 Intermediate Similarity NPD920 Approved
0.7256 Intermediate Similarity NPD1933 Approved
0.7251 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD2344 Approved
0.7243 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7243 Intermediate Similarity NPD7549 Discontinued
0.7231 Intermediate Similarity NPD6823 Phase 2
0.7229 Intermediate Similarity NPD3748 Approved
0.7228 Intermediate Similarity NPD5953 Discontinued
0.7225 Intermediate Similarity NPD4363 Phase 3
0.7225 Intermediate Similarity NPD4360 Phase 2
0.7216 Intermediate Similarity NPD8455 Phase 2
0.7189 Intermediate Similarity NPD7240 Approved
0.7186 Intermediate Similarity NPD6099 Approved
0.7186 Intermediate Similarity NPD6100 Approved
0.7172 Intermediate Similarity NPD7584 Approved
0.717 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7266 Discontinued
0.7126 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7033 Discontinued
0.712 Intermediate Similarity NPD7286 Phase 2
0.7108 Intermediate Similarity NPD6651 Approved
0.7086 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD5353 Approved
0.7076 Intermediate Similarity NPD2309 Approved
0.7073 Intermediate Similarity NPD2313 Discontinued
0.7059 Intermediate Similarity NPD1652 Phase 2
0.7059 Intermediate Similarity NPD1243 Approved
0.7055 Intermediate Similarity NPD6832 Phase 2
0.7053 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD2346 Discontinued
0.7035 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD2799 Discontinued
0.7006 Intermediate Similarity NPD1548 Phase 1
0.7005 Intermediate Similarity NPD7039 Approved
0.7005 Intermediate Similarity NPD7038 Approved
0.7005 Intermediate Similarity NPD2494 Approved
0.7005 Intermediate Similarity NPD2493 Approved
0.6995 Remote Similarity NPD6212 Phase 3
0.6995 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6995 Remote Similarity NPD5242 Approved
0.6995 Remote Similarity NPD6213 Phase 3
0.6994 Remote Similarity NPD2861 Phase 2
0.6985 Remote Similarity NPD8320 Phase 1
0.6985 Remote Similarity NPD8319 Approved
0.6978 Remote Similarity NPD8127 Discontinued
0.6975 Remote Similarity NPD1203 Approved
0.6973 Remote Similarity NPD2163 Approved
0.6971 Remote Similarity NPD7907 Approved
0.6957 Remote Similarity NPD4665 Approved
0.6957 Remote Similarity NPD2403 Approved
0.6957 Remote Similarity NPD4111 Phase 1
0.6946 Remote Similarity NPD5124 Phase 1
0.6946 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6946 Remote Similarity NPD6355 Discontinued
0.6946 Remote Similarity NPD5123 Clinical (unspecified phase)
0.694 Remote Similarity NPD5711 Approved
0.694 Remote Similarity NPD5710 Approved
0.694 Remote Similarity NPD7229 Phase 3
0.6937 Remote Similarity NPD1610 Phase 2
0.6935 Remote Similarity NPD7680 Approved
0.6919 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6919 Remote Similarity NPD3452 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data